Low phosphorylated akt expression in laryngeal cancer: Indications for a higher metastatic risk

International Journal of Radiation Oncology Biology Physics

Volumn 87, Issue 2, 2013, Pages 349-355

  Nijkamp, Monique M ^a   Span, Paul N ^a   Stegeman, Hanneke ^a   Grénman, Reidar ^b   Kaanders, Johannes H A M ^a   Bussink, Johan ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOMATED IMAGE ANALYSIS; EPIDERMAL GROWTH FACTOR RECEPTORS; EPITHELIAL-MESENCHYMAL TRANSITION; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; METHODS AND MATERIALS; REAL-TIME POLYMERASE CHAIN REACTION; SPATIAL RELATIONSHIPS;

BLOOD VESSELS; BODY FLUIDS; CELL CULTURE; CELLS; DISEASES; GLYCOPROTEINS; PATHOLOGY; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; RNA;

TUMORS;

8 [4 (1 AMINOCYCLOBUTYL)PHENYL] 9 PHENYL 1,2,4 TRIAZOLO[3,4 F][1,6]NAPHTHYRIDIN 3(2H) ONE; EPIDERMAL GROWTH FACTOR RECEPTOR; MESSENGER RNA; PIMONIDAZOLE; PROTEIN KINASE B; UVOMORULIN; VIMENTIN;

ADULT; AGED; ARTICLE; BLOOD VESSEL; COMPETITIVE INHIBITION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN CELL; HYPOXIA; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LARYNX CANCER; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; UPREGULATION; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; CADHERINS; CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; LARYNGEAL NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; VIMENTIN;

EID: 84882913964     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2013.05.046     Document Type: Article

References (20)

1. P. Blanchard, B. Baujat, and V. Holostenco Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): A comprehensive analysis by tumor site Radiother Oncol 100 2011 33 40
2. J.A. Bonner, P.M. Harari, and J. Giralt Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck N Engl J Med 354 2006 567 578
3. M.M. Nijkamp, I.J. Hoogsteen, and P.N. Span Spatial relationship of phosphorylated epidermal growth factor receptor and activated AKT in head and neck squamous cell carcinoma Radiother Oncol 101 2011 165 170
4. J. Bussink, A.J. van der Kogel, and J.H. Kaanders Activation of the PI3-K/AKT pathway and implications for radioresistance mechanisms in head and neck cancer Lancet Oncol 9 2008 288 296
5. O. David, J. Jett, and H. LeBeau Phospho-Akt overexpression in non-small cell lung cancer confers significant stage-independent survival disadvantage Clin Cancer Res 10 2004 6865 6871
6. A. Shah, W.A. Swain, and D. Richardson Phospho-akt expression is associated with a favorable outcome in non-small cell lung cancer Clin Cancer Res 11 2005 2930 2936
7. Y.R. Chin, and A. Toker Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancer Cell Signal 21 2009 470 476
8. A. Toker, and M. Yoeli-Lerner Akt signaling and cancer: Surviving but not moving on Cancer Res 66 2006 3963 3966
9. M. Zeisberg, and E.G. Neilson Biomarkers for epithelial-mesenchymal transitions J Clin Invest 119 2009 1429 1437
10. M.M. Nijkamp, P.N. Span, and I.J. Hoogsteen Expression of E-cadherin and vimentin correlates with metastasis formation in head and neck squamous cell carcinoma patients Radiother Oncol 99 2011 344 348
11. J.A. Knowles, B. Golden, and L. Yan Disruption of the AKT pathway inhibits metastasis in an orthotopic model of head and neck squamous cell carcinoma Laryngoscope 121 2011 2359 2365
12. P.F. Rijken, H.J. Bernsen, and J.P. Peters Spatial relationship between hypoxia and the (perfused) vascular network in a human glioma xenograft: A quantitative multi-parameter analysis Int J Radiat Oncol Biol Phys 48 2000 571 582
13. H. Stegeman, J.H. Kaanders, and D.L. Wheeler Activation of AKT by hypoxia: A potential target for hypoxic tumors of the head and neck BMC Cancer 12 2012 463
14. A.K. Gupta, W.G. McKenna, and C.N. Weber Local recurrence in head and neck cancer: Relationship to radiation resistance and signal transduction Clin Cancer Res 8 2002 885 892
15. I.G. Maroulakou, W. Oemler, and S.P. Naber Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice Cancer Res 67 2007 167 177
16. R. Virtakoivu, T. Pellinen, and J.K. Rantala Distinct roles of AKT isoforms in regulating beta1-integrin activity, migration, and invasion in prostate cancer Mol Biol Cell 23 2012 3357 3369
17. R.L. Dillon, R. Marcotte, and B.T. Hennessy Akt1 and akt2 play distinct roles in the initiation and metastatic phases of mammary tumor progression Cancer Res 69 2009 5057 5064
18. K.E. O'Reilly, F. Rojo, and Q.B. She mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt Cancer Res 66 2006 1500 1508
19. S. Chandarlapaty, A. Sawai, and M. Scaltriti AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity Cancer Cell 19 2011 58 71
20. D.L. Wheeler, E.F. Dunn, and P.M. Harari Understanding resistance to EGFR inhibitors - impact on future treatment strategies Nat Rev Clin Oncol 7 2010 493 507